Health

AI systems make industries more efficient, but also pollute our air and water. Future regulation should take public health into account.

Phase 3 HIVEC® HEAT study presented at AUA 2026 highlights progress toward FDA registration and the potential for bladder-preserving treatment in high-risk NMIBC patients.

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

Cambridge-based imaging CRO brings together seven global experts to guide development of non-invasive AI endpoints.

Uniting innovation, equity, and cross-sector collaboration to scale prevention, expand access, and turn cervical cancer into the first cancer eliminated worldwide.

Single treatment induces sustained remission across three autoimmune conditions, signalling expansion beyond oncology.